- Home
- VRDN vs GAM Comparison
VRDN vs GAM Comparison
Compare VRDN & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- GAM
- Stock Information
- Founded
- VRDN 2006
- GAM 1927
- Country
- VRDN United States
- GAM United States
- Employees
- VRDN N/A
- GAM N/A
- Industry
- VRDN Medical Specialities
- GAM Investment Managers
- Sector
- VRDN Health Care
- GAM Finance
- Exchange
- VRDN Nasdaq
- GAM Nasdaq
- Market Cap
- VRDN 1.3B
- GAM 1.4B
- IPO Year
- VRDN N/A
- GAM N/A
- Fundamental
- Price
- VRDN $18.54
- GAM $59.15
- Analyst Decision
- VRDN Strong Buy
- GAM
- Analyst Count
- VRDN 11
- GAM 0
- Target Price
- VRDN $38.80
- GAM N/A
- AVG Volume (30 Days)
- VRDN 767.6K
- GAM 20.1K
- Earning Date
- VRDN 08-06-2025
- GAM 01-01-0001
- Dividend Yield
- VRDN N/A
- GAM 5.74%
- EPS Growth
- VRDN N/A
- GAM N/A
- EPS
- VRDN N/A
- GAM 11.67
- Revenue
- VRDN $305,000.00
- GAM N/A
- Revenue This Year
- VRDN N/A
- GAM N/A
- Revenue Next Year
- VRDN $17,102.33
- GAM N/A
- P/E Ratio
- VRDN N/A
- GAM $3.95
- Revenue Growth
- VRDN 5.90
- GAM N/A
- 52 Week Low
- VRDN $9.90
- GAM $37.32
- 52 Week High
- VRDN $27.20
- GAM $46.48
- Technical
- Relative Strength Index (RSI)
- VRDN 62.06
- GAM 71.38
- Support Level
- VRDN $15.68
- GAM $57.55
- Resistance Level
- VRDN $19.10
- GAM $59.68
- Average True Range (ATR)
- VRDN 1.01
- GAM 0.65
- MACD
- VRDN 0.08
- GAM 0.11
- Stochastic Oscillator
- VRDN 83.63
- GAM 84.46
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.